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any enveloped viruses exploit the class E vacu-
olar protein-sorting (VPS) pathway to bud from
cells, and use peptide motifs to recruit speciﬁc
class E VPS factors. Homologous to E6AP COOH terminus
(HECT) ubiquitin ligases have been implicated as cofactors
for PPXY motif–dependent budding, but precisely which
members of this family are responsible, and how they
access the VPS pathway is unclear. Here, we show that
PPXY-dependent viral budding is unusually sensitive to
inhibitory fragments derived from speciﬁc HECT ubiquitin
ligases, namely WWP1 and WWP2. We also show that
M
 
WWP1, WWP2, or Itch ubiquitin ligase recruitment pro-
motes PPXY-dependent virion release, and that this function
requires that the HECT ubiquitin ligase domain be cata-
lytically active. Finally, we show that several mammalian
HECT ubiquitin ligases, including WWP1, WWP2, and
Itch are recruited to class E compartments induced by
dominant negative forms of the class E VPS ATPase,
VPS4. These data indicate that speciﬁc HECT ubiquitin
ligases can link PPXY motifs to the VPS pathway to induce
viral budding.
 
Introduction
 
The class E vacuolar protein-sorting (VPS) pathway functions at
the limiting membrane of multivesicular bodies (MVBs) during
lumenal vesicle formation and is exploited by the late assembly
or L-domains of enveloped viruses during budding (Katzmann
et al., 2002; Pornillos et al., 2002). Many class E VPS factors are
components of three endosomal sorting complexes required for
transport (ESCRT-I, -II, or -III; Katzmann et al., 2001; Babst et
al., 2002a,b), which are somewhat more elaborate in mammals
than in yeast and are linked by protein interactions between
ESCRT components and bridging factors (Martin-Serrano et al.,
2003a; Strack et al., 2003; von Schwedler et al., 2003). A current
model for viral and MVB vesicle budding invokes the sequential
recruitment of ESCRT-I, -II, and -III. Thereafter, budding occurs
concurrently with the release of ESCRT components from the
MVB membrane induced by an AAA-ATPase, Vps4 (Babst et
al., 1998; Katzmann et al., 2002). The cascade of recruitment
events is initiated by ubiquitin (Hicke, 2001; Katzmann et al.,
2001; Bishop et al., 2002; Pornillos et al., 2002) and/or peptide
motifs in cellular and viral proteins (see below).
Three viral L-domain types with distinguishable but over-
lapping requirements for the various VPS factors are defined by
PT/SAP (Gottlinger et al., 1991; Huang et al., 1995), YPXL/
LXXLF (Puffer et al., 1997; Strack et al., 2003), or PPXY
(Wills et al., 1994) peptide motifs. PTAP motifs recruit ESCRT-I
by binding to Tsg101 (Garrus et al., 2001; Martin-Serrano et al.,
2001; VerPlank et al., 2001; Demirov et al., 2002), whereas
YPXL and LXXLF motifs recruit AIP-1/ALIX, a class E VPS
factor that binds to both ESCRT-I and -III (Martin-Serrano et
al., 2003a; Strack et al., 2003; von Schwedler et al., 2003). All
L-domain types require a subset of class E VPS factors and their
function is blocked by dominant negative forms of ESCRT-III
components (Martin-Serrano et al., 2003a; Strack et al., 2003;
von Schwedler et al., 2003) or VPS4 (Garrus et al., 2001; Martin-
Serrano et al., 2003b; Tanzi et al., 2003).
Thus, PTAP- and YPDL-type L-domains bind directly to
class E VPS factors but how PPXY motifs access the class E
VPS pathway is uncertain. PPXY is a consensus sequence for
interaction with WW-domains, which are present in homologous
to E6AP COOH terminus (HECT) ubiquitin ligases. Although
yeast has a single HECT ubiquitin ligase (Rsp5; Huibregtse et
al., 1995), mammals have elaborated this family of proteins to
 
 
 
10 members (Rotin et al., 2000). Rsp5-mediated ubiquitination
of cargo or transacting factors is required for the endocytosis of
at least some transmembrane proteins and/or for the sorting of
endocytic and biosynthetic cargo into the yeast vacuole (Galan
et al., 1996; Dunn and Hicke, 2001; Katzmann et al., 2004).
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In mammals, the most widely studied member of this family of
proteins, Nedd4, is recruited by PPXY motifs in, for example,
the cytoplasmic domains of the amiloride-sensitive epithelial
Na
 
 
 
 channel (ENaC) and induces its down-regulation (Staub
et al., 1996, 2000). Heretofore, the WW and membrane bind-
ing (C2) domains are thought to be responsible for directing
the localization and substrate recognition of Nedd4/Rsp5 like
proteins, whereas the role of the HECT ubiquitin ligase do-
main has been thought to be confined to modifying cargo or
transacting factors with ubiquitin (Dunn and Hicke, 2001;
Hicke, 2001).
Several studies suggest that Nedd4-like ubiquitin li-
gases play roles in viral budding. Overexpression of various
HECT ubiquitin ligase-derived WW-domains can block viral
budding, and the PPXY motifs in vesicular stomatitis virus
(Harty et al., 1999), Ebola virus (Harty et al., 2000; Yasuda et
al., 2003), Rous sarcoma virus (RSV; Kikonyogo et al.,
2001), human T cell leukemia virus (Bouamr et al., 2003;
Blot et al., 2004; Heidecker et al., 2004; Sakurai et al., 2004),
and Mason Pfizer monkey virus (Yasuda et al., 2002) have
been reported bind to Nedd4, LDI-1, LDI-2, BUL1, or
WWP1 HECT ubiquitin ligases. PPXY motifs can also cause
retroviral Gag proteins to become ubiquitinated and an
ENaC-derived peptide sequence exhibits L-domain activity in
the context of a retroviral Gag protein (Strack et al., 2000,
2002). Other observations suggest that ubiquitin itself plays a
general role in viral budding, although the details of its partic-
ipation are not understood. Proteasome inhibitors block the
release of certain rhabdoviruses (Harty et al., 2001) and some
retroviruses (Patnaik et al., 2000, 2002; Schubert et al., 2000;
Strack et al., 2000; Ott et al., 2002, 2003), perhaps due to de-
pletion of free ubiquitin. Importantly, these inhibitors induce
a defective viral assembly phenotype that resembles that of
L-domain mutants.
Because it remained uncertain as to precisely which
HECT ubiquitin ligases mediate PPXY motif–dependent viral
budding and how the class E VPS pathway is accessed by these
proteins, we surveyed an array of HECT ubiquitin ligases and
found that fragments of the HECT ubiquitin ligases WWP1 and
WWP2 are unusually potent and specific inhibitors of viral
PPXY motif function. The sequence requirements for the bind-
ing of the murine leukemia virus (MLV) L-domain motif to
WWP1, WWP2, and the closely related ligase, Itch, but not
Nedd4 precisely recapitulate those required for virus release.
Moreover, WWP1 can be recruited by PPXY motifs to sites of
MLV and Ebola virus particle budding from cells. Importantly,
we show that these ligases can actively promote PPXY-depen-
dent virus particle release, and that this function requires an en-
zymatically active HECT domain. Finally, we also show that
several HECT ubiquitin ligases display characteristics of class
E VPS factors in that they are recruited to endosomal compart-
ments induced by dominant negative VPS4 and, surprisingly,
that the HECT domain is largely responsible for this property
in WWP1. Together, these data indicate that the enzymatic ac-
tivity of particular HECT ubiquitin ligases and a physical asso-
ciation with the class E VPS pathway promotes PPXY motif–
dependent viral budding.
 
Results
 
MLV budding induced by viral and cellular 
WW-domain binding PPXY motifs
 
To investigate the cofactor requirements for PPXY-dependent
viral budding, we used chimeric MLVs, shown schematically in
Fig. 1 A. These contained PPXY motifs and flanking amino ac-
ids from the cellular PPXY motif in the cytoplasmic domain of
ENaC, or viral L-domain motifs from RSV p2b and Ebola vi-
rus VP40 (EbVp40). An MLV provirus containing a PTAP
L-domain from HIV-1 p6 in place of the MLV PPPY motif
(Yuan et al., 2000), was included for control purposes. Each re-
combinant MLV provirus generated infectious virion particles
upon transfection of 293T cells (Fig. 1 B), at least 100-fold more
efficiently than a control construct (MLV/dPY), which lacks the
PPPY motif and exhibits a profound late budding defect (Yuan
et al., 2000). Thus, each of these cellular and viral PPXY motifs
could functionally substitute for the MLV L-domain.
To identify specific HECT ubiquitin ligases that could
potentially be important for PPXY-dependent viral budding,
we applied two criteria. First, we tested YFP-fused WW-
domain fragments from the majority of known mammalian
HECT ubiquitin ligases for their ability to inhibit MLV bud-
ding, mediated by each of the PPXY motifs. As can be seen in
Fig. 1 C, each of the YFP-WW-domain fusion proteins was ex-
pressed at similar levels. However, YFP-WW-domain fusion
proteins based on WWP1 and WWP2 were unusual in that they
inhibited infectious virion production mediated by all of the
PPXY motifs tested by 10–50-fold (Fig. 1 D). Other YFP-WW-
domain fusion proteins had weak or absent inhibitory activity on
budding mediated by the MLV, RSV, and Ebola PPXY motifs.
Conversely, most of the YFP-WW-domain fusion proteins, in-
cluding those based on WWP1, WWP2, Nedd4, Ned4-L, Itch,
and BUL1 strongly inhibited ENaC PPXY motif–dependent vi-
rion production (Fig. 1 D). Importantly, inhibition by YFP-WW-
domain fusion proteins was specific because MLV/HIVp6 re-
lease was largely unaffected (Fig. 1 D).
Using yeast 2-hybrid assays, we next tested the ability of
each WW-domain to bind to MLV Gag proteins containing the
various PPXY motifs. The isolated WW-domains from WWP1,
WWP2, and Itch could not be used in this assay, due to toxic-
ity in yeast and constitutive transcriptional activation activity.
Therefore, the full-length proteins were used in these cases. As
can be seen in Fig. 1 E, the full-length Nedd4 protein and the
Nedd4
 
WW
 
 fragment exhibited the same specificity for binding to
the various PPXY motifs. The intact MLV Gag protein bound to
Nedd4, Nedd4
 
WW
 
 Nedd4-L
 
WW
 
, WWP1, WWP2, and Itch, and
these interactions required the PPXY motif. The MLV/ENaC
Gag protein bound to all the proteins tested except Smurf1 and
Smurf2. Conversely, MLV/RSVp2 and MLV/Ebola Gag pro-
teins bound only to WWP1, WWP2, and Itch. Overall, the
ability of the WW-domains to bind to PPXY motifs in the yeast
2-hybrid assay correlated quite well with the ability of the corre-
sponding YFP-WW-domain fusion proteins to act as dominant
inhibitors in the viral budding assay, although there were some
WW-domains (Nedd4, Nedd4-L, Itch) that appeared capable of
binding to the intact MLV Gag protein that had relatively mod- 
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est, albeit significant, activity as MLV budding inhibitors (three-
fold inhibition). That MLV, ENaC, RSVp2, and Ebola PPXY
motifs could bind to endogenous WWP1, WWP2, and Itch ubiq-
uitin ligases, was determined using co-precipitation assays. Each
of these ubiquitin ligases was co-precipitated with GST-p12 fu-
sion proteins containing MLV, ENaC, RSV, and Ebola PPXY
motifs, but not with GST-p12(dPY) (Fig. 1 F). Other ubiquitin
ligases were not tested in this assay, either because antibodies
were not available or because we were unable to detect them in
293T cell lysates using commercially available antisera.
 
Sequence requirements for MLV
L-domain function and HECT ubiquitin 
ligase binding
 
If PPXY motifs indeed mediate viral budding by recruiting
specific HECT ubiquitin ligases, then the sequence require-
ments for viral budding activity should closely match those
for binding to the ligases. We tested a series of six, single
amino acid to alanine, point mutants scanning through MLV
Gag(p12) residues 161–166 (DPPPYR). Each mutation was
tested in the context of an MLV proviral plasmid for effects on
Figure 1. PPXY motif binding and inhibition of MLV budding by HECT ubiquitin ligase WW-domains. (A) Chimeric MLVs used in this study: the PPPY motif
was deleted or replaced by the indicated peptide sequences of viral or cellular origin. (B) Infectious MLV production after transfection of 293T cells with
wild-type and chimeric proviral plasmids, measured by chemiluminescent  -galactosidase assay after infection of HeLa P4/R5 indicator cells. The dashed
line indicates the background  -galactosidase activity, which was obtained using MLV/dPY. Error bars indicate the SD from the mean of triplicate mea-
surements. (C) Western blot analysis of YFP-WW-domain fusion protein expression in 293T cells. (D) Effect of YFP-WW-domain fusion protein expression
on MLV production. The results are plotted as the percentage of the infectious virus production observed in the presence of unfused YFP, which was similar
to that shown in B. Error bars indicate the SD from the mean of triplicate measurements. (E) Yeast two-hybrid analysis of the interactions between the
indicated PPXY motifs and WW-domains or intact HECT ubiquitin ligases. The mean level of  -galactosidase expression measured as optical density
units at 540 nm (OD540) in three pools of Y190 cells, expressing the indicated Gal4 and VP16 fusion proteins is shown. Absence of a bar indicates
background levels of  -galactosidase. Error bars indicate the SD from the mean of triplicate measurements. (F) GST-p12 proteins derived from the
chimeric MLVs were expressed in 293T cells and samples of proteins that bound to glutathione-Sepharose beads were analyzed by Western blot with
WWP1, WWP2, and Itch-specific antibodies (top). Equivalent expression and loading of the GST-p12 fusion proteins was verified by Coomassie blue
staining of the glutathione-bound fraction (bottom). 
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virus release, and in the context of Gag and GST-p12 proteins
for effects on binding to HECT ubiquitin ligases. As can be
seen in Fig. 2 A, MLV proviral plasmids carrying the APP-
PYR, DPPAYR, and DPPPYA mutations generated virions
with similar efficiency to wild-type MLV, whereas release of
the DAPPYR, DPAPYR, and DPPPAR mutant virions was at-
tenuated. Loss of viral budding was accompanied by a Gag
processing defect with accumulation of unprocessed Gag and
aberrant Gag fragments in cell lysates and little mature p30
capsid formation (Fig. 2 A). Virion release by the panel of
MLV mutants correlated with the ability of Gag to bind to
WWP1, WWP2, and Itch, but not to Nedd4 or Nedd4L (Fig. 2
B). In particular, the DPPAYR Gag mutant was devoid of
Nedd4 or Nedd4L binding activity (Fig. 2 B), but supported ef-
ficient virion release (Fig. 2 A). The DAPPYR, DPAPYR,
and DPPPAR mutations inhibited co-precipitation of WWP1,
WWP2, and Itch from 293T cell lysates by GST-p12 fusion
proteins, whereas the APPPYR, DPPAYR, and DPPPYA mu-
tations had no effect (Fig. 2 C), concordant with the findings in
the virus release and yeast 2-hybrid assays (Fig. 2, A and B). A
small amount of WWP2 co-precipitation was detected with the
DAPPYR mutant (Fig. 2 C) and this mutant supported a low re-
sidual level of virion formation (Fig. 2 A). Because the WWP1
and Itch antisera were less efficacious than the WWP2 anti-
serum, it was unclear whether our inability to detect WWP1
and Itch co-precipitation by GST-p12(DAPPYR) was due to
real differences in their binding specificity as compared with
WWP2. Similar GST-p12 mutant coprecipitation experiments
could not be done with Nedd4. This was because Nedd4 did
not bind efficiently to wild-type GST-p12, even when over-
expressed, despite interaction with MLV Gag in the yeast
2-hybrid assay. In fact, Nedd4 was only efficiently coprecipi-
tated by the GST-p12(ENaC) protein (unpublished data).
 
WWP1 recruitment to sites of MLV 
budding
 
The aforementioned data suggested WWP1, WWP2, and Itch
as the most likely candidates for recruitment by PPXY motifs
to support viral budding. We initially selected WWP1 for more
detailed analyses because it had the most robust and broad ac-
tivity in the PPXY binding and budding-inhibition assays (Fig.
1). We constructed a series of truncation mutants containing ei-
ther one or two of the three WWP1 segments (C2, WW and
HECT; Fig. 3 A) and expressed them as YFP-fusion proteins.
When expressed alone, a full-length YFP-WWP1 fusion pro-
tein localized primarily to the plasma membrane (Fig. 3 B).
The C2 domain governed this phenotype, because a YFP-
WWP1
 
C2
 
 fusion protein retaining this element exhibited the
same localization, whereas truncated YFP-WWP1 fusion pro-
teins lacking the C2 domain exhibited nuclear localization or
were distributed throughout the cell. Upon coexpression of
YFP-WWP1 with an MLV Gag-CFP fusion protein, the YFP
and CFP signals were almost perfectly coincident (Fig. 3 C).
This near complete colocalization required that the MLV Gag-
CFP protein encoded an intact PPXY motif. Indeed, when
YFP-WWP1 and MLV Gag(dPY)-CFP were coexpressed, both
YFP and CFP signals were primarily at the plasma membrane,
but they did not colocalize to any greater extent than would two
signals that were randomly distributed at the plasma membrane
(Fig. 3 C). In addition, YFP-WWP1
 
WW
 
 that was primarily lo-
calized in the nucleus when expressed alone (Fig. 3 B), was re-
localized to the plasma membrane upon coexpression with
MLV Gag-CFP, in a PPPY motif–dependent manner (Fig.
3 C). YFP-fusion proteins containing the WW domains of
WWP2 and Itch also exhibited nuclear localization when ex-
Figure 2. Sequence requirements for MLV L-domain activity and interaction
with HECT ubiquitin ligases. (A) Virion production by 293T cells transfected
with MLV proviral plasmids bearing the indicated mutations in the DPPPYR
sequence. Virion and cell lysates were analyzed by Western blotting with
 MLV Gag antibodies. (B) Yeast two-hybrid analysis of interactions be-
tween the indicated mutant MLV Gag proteins and HECT ubiquitin ligases.
The mean level of  -galactosidase expression in yeast transformed with
the indicated Gal4 and VP16 Gag and ubiquitin ligase fusion proteins is
shown. Error bars indicate the SD from the mean of triplicate measure-
ments. (C) Binding of endogenous WWP1, WWP2, and Itch to wild-type
and mutant GST-p12 proteins expressed in 293T cells. The top panels
show Western blots of the glutathione-bound proteins, probed with the
indicated specific antibodies and the bottom panel shows Coomassie blue
staining of the glutathione-bound GST-p12 proteins, verifying equivalent
expression and loading. 
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pressed alone but were relocalized to the plasma membrane
upon expression with MLV Gag-CFP (unpublished data).
 
Inhibition of MLV release by WWP1 
fragments and mutants suggests that 
HECT domains serve enzymatic and 
additional functions
 
The findings that isolated WW-domains from WWP1 and
WWP2 bound to each of the PPXY motifs and acted as potent
dominant inhibitors of PPXY-dependent viral budding suggested
that they compete with a cellular factor that would ordinarily be
recruited by PPXY motifs. However, it has not previously been
shown that the competed cellular cofactor is itself a HECT ubiq-
uitin ligase. Moreover, although previous studies have docu-
mented that WW-domains can inhibit viral budding, their po-
tency was significantly less than that of YFP-WWP1
 
WW
 
 and
YFP-WWP2
 
WW
 
 (Fig. 1). Therefore, we next determined what
protein domains and activities were required to be eliminated in
order to render WWP1 a dominant inhibitor of viral budding,
and whether the effects induced by these manipulations were
specific to PPXY-dependent viral budding. The various trun-
cated YFP-WWP1 fusion proteins are shown schematically in
Fig. 3 A. Their expression levels after transfection of varying
amounts of plasmid is shown in Fig. 4 A and are important
Figure 3. WWP1 recruitment to sites of MLV budding. (A) Domain organization of WWP1 showing the residues at which the protein was truncated to
derive the various deletion mutants. (B) Cellular localization of WWP1 and deletion mutants in 293T cells analyzed by deconvolution microscopy. Shown
are full-length YFP-WWP1 (residues 1–922) YFP-WWP1WW-HECT (341–922), YFP-WWP1C2-WW (1–547), YFP-WWP1C2 (1–341), YFP-WWP1WW (341–547),
and YFP-WWP1HECT (547–922). (C) Analysis of YFP-WWP1 and YFP-WWP1WW localization in 293T cells when coexpressed with wild-type or dPY mutant
MLV Gag-CFP as indicated. Images acquired with the CFP filter set (left) are pseudo-colored red for clarity and are combined with those acquired with the
YFP filter set (middle, pseudo-colored green) to generate overlaid images (right). For the Gag-CFP   YFP-WWP1 and Gag dPY-CFP   YFP-WWP1 combi-
nations, two sets of images showing a whole cell (top) and an expanded portion of the plasma membrane (bottom) are shown. 
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for interpreting the results in Fig. 4 B. As can be seen in
Fig. 4 (B and C), neither full-length YFP-WWP1 nor YFP-
WWP1
 
WW-HECT
 
 exhibited inhibitory or enhancing effects on
MLV release, as assessed by infectious particle output or West-
ern blot assays, despite the fact that the YFP-WWP1
 
WW-HECT
 
 pro-
tein was expressed at a considerably higher level than full-length
YFP-WWP1. The YFP-WWP1 and YFP-WWP1
 
WW-HECT
 
 pro-
teins carrying an active site mutation (C890S) were expressed at
the same level as their wild-type counterparts and modestly in-
hibited MLV production (Fig. 4, B and C). Interestingly, YFP-
WWP1
 
WW
 
 was a more potent inhibitor of budding than was
YFP-WWP1
 
WW-HECT(C890S)
 
, and reduced infectious viral output by
nearly 100-fold, even though it was expressed at only a margin-
ally higher level. Note that the only difference between these two
proteins is the presence or absence of a catalytically inactive
HECT domain. However, by far the most potent inhibitor of
MLV budding was the YFP-WWP1
 
C2-WW
 
 protein, which de-
creased infectious MLV release by 500-fold to virtually unde-
tectable levels (Fig. 4 B) even though it was expressed at a con-
siderably lower level than YFP-WWP1
 
WW
 
 (Fig. 4 A). We
Figure 4. Inhibition of MLV release by WWP1 fragments. (A) Increasing amounts of the indicated YFP-WWP1-derived expression plasmids were trans-
fected in 293T cells and fusion protein expression was monitored by Western blotting with an  GFP antibody. (B) Effect of YFP-WWP1 fragments on infectious
wild-type MLV or MLV/HIVp6 release, measured by cotransfecting MLV proviral plasmids with increasing amounts of the indicated YFP-WWP1-derived
expression plasmids. Infectious MLV virion production was measured as in Fig. 1. The assay background is indicated as a dotted line. Error bars indicate
the SD from the mean of triplicate measurements. (C) Western blot analysis, using an  MLV Gag antibody, of cell lysates and extracellular MLV virions,
after transfection of 293T cells with wild-type MLV or MLV/HIVp6 proviral plasmids and 200 ng of the indicated YFP-WWP1 expression plasmid derivatives.
(D) Galleries of electron microscopic images of arrested and aberrant budding structures observed in 293T cells transfected with the MLV/dPY proviral
plasmid or a wild-type MLV proviral plasmid and plasmids expressing the indicated YFP-WWP1 fragments. 
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suspect that the reason YFP-WWP1
 
C2-WW
 
 was a much more po-
tent inhibitor than YFP-WWP1
 
WW
 
 was because it is constitu-
tively localized at the plasma membrane (Fig. 3 A), whereas
YFP-WWP1
 
WW
 
 is primarily nuclear. YFP-WWP1
 
C2-WW
 
 was ex-
pressed at approximately the same level as the full-length YFP-
WWP1
 
C890S
 
 protein (Fig. 4 A) and, therefore, differs from it only
in the fact that it lacks a catalytically inactive HECT domain.
Nevertheless, it inhibited MLV budding 
 
 
 
50-fold more potently
(Fig. 4 B). Thus, the ability of the WW and C2-WW fragments
of WWP1 to act as potent inhibitors of PPXY-dependent MLV
budding can be partly reversed by restoring a catalytically inac-
tive HECT domain and completely reversed by restoring an ac-
tive HECT domain. Importantly, each of these inhibitors had
only marginal effects on MLV/HIVp6 release (Fig. 4, B and C).
Moreover, electron microscopic analysis of cells coexpressing
MLV and either YFP-WWP1
 
WW
 
 or YFP-WWP1
 
C2-WW
 
 (Fig. 4 D)
revealed that the inhibitory WWP1 fragments induced a late bud-
ding defect similar to that observed upon mutation of the PPXY
L-domain (Yuan et al., 2000), with accumulation of numerous
incompletely budded virions, and formation of aberrant budding
structures including tubes and chains of linked virions. These
budding structures were never observed upon transfection of an
MLV proviral plasmid alone (unpublished data).
 
EbVP40 can recruit WWP1 and of 
WWP1 fragments block EbVP40 particle 
formation
 
Although the protein sequence of EbVP40 and the morphology
of EbVP40 particles is quite different to those of retroviral Gag
proteins, EbVP40 particle release also requires L-domains. In
this case, overlapping PTAP and PPXY motifs contribute to
overall activity (Strack et al., 2000; Martin-Serrano et al., 2001,
2004; Licata et al., 2003). Therefore, we next investigated
whether EbVP40 could recruit WWP1. As was found with
MLV Gag, EbVP40 bound to WWP1 in yeast 2-hybrid assays
(Fig. 5 A), and PPXY motif mutations (P11L or Y13A) that
abolish EbVP40 budding (Martin-Serrano et al., 2004) abol-
ished WWP1 binding. Moreover, EbVP40 particle release was
reduced to almost undetectable levels by expression of YFP-
WWP1
 
WW
 
 or YFP-WWP1
 
C2-WW
 
 proteins but was unaffected by
full-length YFP-WWP1 (Fig. 5 B). As a control, an NH
 
2
 
-termi-
nal fragment (residues 1–157) of Tsg101 that occludes PTAP
motifs also inhibited EbVP40 particle release. Finally, coex-
pression of CFP-EbVP40 with YFP-WWP1
 
WW
 
 resulted in a
dramatic relocalization of YFP-WWP1
 
WW
 
 from the nucleus to
filamentous projections, formed at the plasma membrane by
CFP-EbVP40, and this property was eliminated by single
amino acid substitutions in the EbVP40 PPXY motif (Fig. 5 C).
Thus, the EbVP40 protein behaved in much the same way as
MLV Gag in terms of its ability to recruit WWP1 and its sensi-
tivity to inhibitors based on WWP1.
 
Attenuation of MLV budding by a 
dominant negative WWP1 fragment or by 
a PPXY motif mutation is reversed by 
HECT ubiquitin ligase overexpression
 
Although fragments of WWP1 and WWP2 were uniquely po-
tent dominant inhibitors of PPXY motif–dependent viral bud-
ding, it was possible that they could act by competing with
some entirely distinct cellular cofactor for binding to PPXY
motifs. Therefore, we sought more direct evidence that HECT
ubiquitin ligases are required for PPXY-dependent viral bud-
ding. Unfortunately, siRNAs that depleted WWP1 or WWP2
also appeared to reduce cell viability (unpublished data).
Therefore, we pursued two alternative strategies. First, we in-
hibited MLV budding to 
 
 
 
5–7% of its normal level using a
selected dose of YFP-WWP1
 
WW
 
 expression plasmid. There-
after, infectious virion production could be partly restored, to
 
 
 
30% of its uninhibited level, by coexpression of a YFP-
WWP1
 
WW-HECT
 
 protein (Fig. 6 A). This restoration of budding
was not due to inhibition of YFP-WWP1
 
WW
 
 expression (Fig. 6
Figure 5. WWP1 is recruited by EbVp40. (A) The NH2-terminal 16 aa of
EbVP40 are shown and residues whose mutation selectively ablate the
PTAP motif (P7L) or the PPXY motif (P11L and Y13A) are underlined.
Shown below is a yeast two-hybrid analysis of wild-type and mutant VP16-
EbVP40 binding to Gal4-WWP1 or Gal4-Tsg101.  -galactosidase activity
in yeast expressing these fusion proteins was measured as in Fig. 1. Error
bars indicate the SD from the mean of triplicate measurements. (B) Effect
of WWP1 and Tsg101 fragments on EbVP40 particle release. The indi-
cated YFP-fusion proteins were coexpressed with Myc epitope-tagged
EbVP40. Cell and extracellular virus-like particle (VLP) lysates were ana-
lyzed by Western blot with an  Myc antibody. (C) EbVP40 recruitment of
WWP1WW to sites of particle assembly. 293T cells expressing YFP-
WWP1WW and wild-type or P11L mutant forms of CFP-EbVP40 were ana-
lyzed by deconvolution microscopy as in Fig. 3 except that a composite of
several optical sections is shown to facilitate filament visualization. 
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B). Rather, we conclude that a functional cofactor (YFP-
WWP1
 
WW-HECT
 
) can compete with the inhibitor (YFP-WWP1
 
WW
 
)
to restore viral budding. Importantly, YFP-WWP1
 
WW-HECT(C890S)
 
did not restore viral budding, indicating that a catalytically ac-
tive HECT domain was required (Fig. 6 A). This conclusion
held when MLV Gag expression and budding was measured by
Western blotting and the experiment was elaborated to include
the chimeric MLV/ENaC virus containing the cellular PPXY
motif (Fig. 6 C). In both cases, the rescuing YFP-WWP1
 
WW-HECT
 
protein slightly reduced the level of cell associated MLV Gag,
corrected the Gag processing defect that was induced by YFP-
WWP1
 
WW
 
 expression and partly restored particle release.
Again, this effect required that the rescuing YFP-WWP1
 
WW-HECT
 
protein had an intact active site (Fig. 6 C), indicating that ubiq-
uitin ligation is required for optimal MLV release.
As was shown in Fig. 2 A, one of the alanine scanning mu-
tants of the MLV L-domain (DAPPYR), exhibited a reduced, but
detectable, residual level of virion formation (
 
 
 
10% of that of
wild-type MLV). We reasoned that attenuation was likely due to
reduced affinity of the L-domain for an essential cofactor, and
could potentially be reversed by overexpression of that cofactor.
As can be seen in Fig. 6 D, attenuated DAPPYR mutant MLV
Figure 6. HECT ubiquitin ligases mediate PPXY-dependent viral budding. (A) Restoration of infectious MLV release from 293T cells transfected with MLV
proviral DNA and an inhibitory YFP-WWP1WW expression plasmids. “Rescuing” plasmids encoded YFP-WWP1WW-HECT or YFP-WWP1WW-HECT(C890S) as indicated.
Infectious virus release, measured using HeLa P4R5 indicator cells, is plotted as a proportion of that obtained in the absence of inhibitory YFP-WWP1WW
protein expression. Error bars indicate the SD from the mean of triplicate measurements. (B) Western blot analysis using  GFP antibodies showing expres-
sion of the inhibitory and “rescuing” YFP-fusion proteins in cell lysates. (C) Western blot analysis of cell and virion lysates using  MLV Gag antibodies
upon coexpression of MLV with the inhibitory YFP-WWP1WW and “rescuing” YFP-WWP1WW-HECT fusion proteins. In this experiment, both the wild-type (left)
and the chimeric MLV/ENaC (right) proviral plasmids were used. (D) Restoration of Gag processing and virion release by a budding-attenuated MLV
mutant (DAPPYR) upon overexpression of the indicated YFP-fusion proteins (left). Wild-type MLV was used as a control (right). Cell and virion lysates were
analyzed by Western blotting with  MLV Gag antibodies. The bottom left panel shows Western blot analysis of YFP-fusion protein expression in cell lysates.
(E) Rescue of infectious DAPPYR mutant MLV release by WWP1 overexpression. 293T cells were transfected as in D and infectious virus release was
measured using HeLa P4R5 indicator cells as in Fig. 1. Error bars indicate the SD from the mean of triplicate measurements. 
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release and Gag processing was indeed restored to near wild-
type levels by overexpression of YFP-WWP1, YFP-WWP2, or
YFP-Itch. Overexpression of these HECT ubiquitin ligases did
not enhance wild-type MLV budding (Fig. 6 D). YFP-WWP1-
induced MLV (DAPPYR) release resulted in the formation of in-
fectious virions (Fig. 6 E), indicating that authentic virus particle
formation occurred. The ability of YFP-WWP1 to restore attenu-
ated MLV (DAPPYR) budding was eliminated by the C890S ac-
tive site mutation (Fig. 6, D and E) but both WWP1 and WWP2
proteins lacking the C2 membrane-binding domain retained the
ability to induce release (Fig. 6 D). It should be noted, however,
that YFP-WWP1/2
 
WW-HECT
 
 proteins were expressed at a higher
level and may not be as active as the full-length ligases.
 
Recruitment of HECT ubiquitin ligases to 
VPS4-induced endosomes
 
These data demonstrate that certain HECT ubiquitin ligases can
mediate PPXY-dependent viral budding and that their enzymatic
activity is required for this function. However, because WWP1
fragments completely lacking the HECT domain were substan-
tially more potent dominant inhibitors of budding that those con-
taining a catalytically inactive HECT domain (Fig. 4), we investi-
Figure 7. HECT ubiquitin ligases are recruited to VPS4-induced endosomal structures. (A) YFP-fused full-length WWP1 (top), WWP1C2 and WWP1WW
(center), and WWP1HECT (bottom) protein localization in 293T cells in the presence of either wild-type CFP-VPS4 or E228Q mutant CFP-VPS4(DN) as indicated.
Cells were examined by deconvolution microscopy and each set of three panels shows images acquired using YFP and CFP filter sets alongside overlaid
images as in Fig. 3. (B) YFP-WWP2, -Itch, or -Nedd4 fusion protein localization upon coexpression with wild-type (left) or DN mutant (right) CFP-VPS4. 
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gated the possibility that this protein domain may serve some
additional function, perhaps class E VPS factor recruitment. Us-
ing yeast 2-hybrid and/or co-precipitation assays (Martin-Serrano
et al., 2003a) we tested whether WWP1 or WWP2 could bind to
an array of class E VPS factors, including all known components
of mammalian ESCRT-I, -II, and -III as well as Hrs, HBP, AIP1/
ALIX, LIP-5, VPS4, and the AIP1/ALIX binding proteins
CIN85 and CMS. These results were uniformly negative (unpub-
lished data). However, a characteristic property of class E VPS
pathway components is that they are often relocalized to aberrant
endosomes induced by VPS4 ablation in yeast (Katzmann et al.,
2001; Babst et al., 2002a,b) or by expression of catalytically inac-
tive VPS4(DN) mutants in mammalian cells (Bishop and Wood-
man, 2001). This is probably because most class E VPS factors,
including VPS4 itself, cycle on and off the limiting membrane of
late endosomes and their disassembly and release requires VPS4
activity. In the absence of VPS4 overexpression (Fig. 3) or in the
presence of wild-type CFP-VPS4, which is distributed diffusely
in the cytoplasm at steady state (Fig. 7 A), YFP-WWP1 localized
primarily at the plasma membrane. However, upon coexpression
with CFP-VPS4(DN), YFP-WWP1 accumulated on aberrant
CFP-VPS4(DN)-induced endosomes (Fig. 7 A). Surprisingly,
this property of WWP1 appeared, at least in part, to be conferred
by the HECT domain, because YFP-WWP1
 
HECT
 
 also accumu-
lated on VPS4(DN)-induced endosomes, whereas YFP-WWP1
 
C2
 
remained at the plasma membrane and YFP-WWP1
 
WW
 
 exhibited
only a marginal tendency to relocalize (Fig. 7 A). Although the
YFP-WWP1
 
C2-WW
 
 protein exhibited some recruitment to CFP-
VPS4(DN)-induced endosomes (unpublished data), this tendency
was clearly reduced as compared with full-length YFP-WWP1.
Moreover, full-length YFP-WWP1 but not YFP-WWP1
 
C2-WW
 
 ap-
peared to enhance the formation of CFP-VPS4(DN)-labeled en-
dosomes (unpublished data).
Other HECT ubiquitin ligases, namely WWP2, Itch, and
Nedd4, also colocalized with CFP-VPS4(DN) (Fig. 7 B). How-
ever, they differed from WWP1 in that they were primarily lo-
calized in punctate or vesicular structures when expressed
alone or with wild-type CFP-VPS4. Surprisingly, wild-type
CFP-VPS4 was partly recruited to the punctate structures
containing YFP-WWP2, YFP-Itch, or YFP-Nedd4 (Fig. 7 B).
Thus, although we were unable to detect direct interactions be-
tween HECT ubiquitin ligases and known class E VPS factors,
these findings suggest that HECT ubiquitin ligases might inter-
act with an unknown component of the class E pathway via in-
teractions involving the HECT domain.
 
Discussion
 
These data show that particular HECT ubiquitin ligases can act
as a functional interface between viral or cellular proteins that
contain PPXY motifs and the class E VPS pathway. Previously,
HECT ubiquitin ligases were thought to influence the fate of
their substrates because ubiquitin modification is responsible
for downstream events, including entry into the MVB sorting
pathway (Rotin et al., 2000; Dunn and Hicke, 2001; Hicke,
2001; Katzmann et al., 2001, 2004; Bishop et al., 2002;
Marchese et al., 2003; Alam et al., 2004). Two lines of evidence
presented herein suggest that HECT domains have functions in
addition to tagging substrates with ubiquitin. First, WWP1 frag-
ments completely lacking a HECT domain were much more po-
tent inhibitors of PPXY motif function than otherwise equiva-
lent proteins carrying catalytically inactive HECT domains.
Second, several HECT ubiquitin ligases were recruited to
VPS4(DN)-induced endosomal compartments. Recent studies
have shown that the Rsp5, the sole HECT ubiquitin ligase in
yeast localizes to the class E compartment induced by Vps4 ab-
lation, but C2 domain–phosphoinositide interactions appear to
be responsible for recruitment therein (Dunn et al., 2004). We
found that the isolated HECT domain of WWP1, which is not
expected to exhibit membrane binding activity, appeared to be
sufficient to serve as a signal for recruitment to VPS4(DN) in-
duced compartments. Although we were unable to demonstrate
a direct interaction between HECT ubiquitin ligases and any
known class E VPS factor, these observations suggest that a
physical interaction between HECT domains and some compo-
nent of the class E pathway exists, perhaps involving some as
yet unidentified bridging factor. HECT domains can participate
in specific protein–protein interactions (Huibregtse et al., 1993;
Huang et al., 1999) but no known interaction would obviously
lead to class E VPS factor recruitment.
Although our analyses suggest that HECT domains have
unanticipated additional functions, they also clearly demon-
strate that the HECT active site, and presumably therefore,
ubiquitination of a substrate protein, is required for PPXY-
dependent viral budding. What the functional target of ubiqui-
tination is in this context is unclear. Several studies have shown
that retroviral Gag proteins are ubiquitinated (Ott et al., 2000;
Strack et al., 2000; Blot et al., 2004; Martin-Serrano et al.,
2004), and this may stabilize the localization of ubiquitin-bind-
ing class E VPS factors at sites of viral budding. Alternatively,
other factors, including the class E VPS factor Hrs, are also
ubiquitinated during cellular cargo trafficking (Polo et al., 2002)
in at least some instances by HECT ubiquitin ligases (Marchese
et al., 2003). In addition, there is clear evidence that Rsp5-
dependent trafficking in yeast can require ubiquitination of sub-
strates other than the cargo protein (Dunn and Hicke, 2001). In
principle, therefore, ubiquitination of factors other than the viral
protein could influence their function in viral budding.
Which HECT ubiquitin ligase is actually used during
PPXY-dependent viral budding and receptor trafficking?
Overexpressed YFP-fusions of WWP1, WWP2, and Itch ex-
hibited distinct patterns of localization, but each of these li-
gases bound to the MLV L-domain with the sequence speci-
ficity expected of a genuine PPXY-type L-domain cofactor.
In addition, each of these proteins was recruited to sites of vi-
ral budding by MLV Gag and restored the release of a partly
defective MLV Gag mutant. All three of these ligases are
ubiquitously expressed (Wood et al., 1998) suggesting that
some degree of functional redundancy exists, at least for
PPXY-dependent viral budding. In addition, these data do not
necessarily exclude a role for other HECT ligases such as
Nedd4, which bound to a more limited subset of viral PPXY
motifs, as viral budding cofactors. However, Nedd4 was not
relocalized by MLV Gag or Ebola VP40 (unpublished data) 
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and Nedd4 binding activity was not required for MLV
L-domain function. Nonetheless, like other HECT ubiquitin
ligases, Nedd4 exhibited evidence of interaction with the class
E pathway, because it was recruited to VPS4(DN)-induced
compartments. We suppose that multiple HECT ubiquitin li-
gases can recruit class E VPS factors and precisely which one
is used during viral budding likely depends on expression lev-
els in infected tissues, perhaps subcellular localization, and
the particular sequence context of the viral PPXY motif.
However, at least three PPXY-type L-domains from widely
divergent enveloped viruses, as well as the cellular ENaC
PPXY motif, proved capable of recruiting WWP1, WWP2,
and Itch. Interestingly, based on sequence comparison, these
three proteins form a readily distinguishable subgroup of the
mammalian HECT ubiquitin ligases.
Although this study focused on the use of HECT ubiq-
uitin ligases and VPS factors during PPXY motif–dependent
viral budding, similar considerations likely apply to the recruit-
ment of HECT ubiquitin ligases by cellular proteins to facili-
tate receptor internalization and entry into the MVB sorting
pathway. The elaboration of this family of proteins by mam-
mals as compared with yeast might be to cope with a wider
range of substrates. Alternatively, it may be that different li-
gases act at different points in mammalian trafficking path-
ways. The cellular PPXY motif from the cellular protein ENaC
appeared particularly promiscuous with respect to WW-domain
binding, and it may be that multiple ligases are exploited by a
single motif at different locations during the trafficking of a
protein within a cell. In the absence of PPXY motif–containing
viral proteins, the localization of overexpressed WWP1 was
governed by the C2-domain that directed the protein to the
plasma membrane, and the differential localization of the over-
expressed YFP-HECT ubiquitin ligase fusion proteins suggests
that endogenous proteins may be located on distinct cellular
membranes. In the context of viral budding, constitutive mem-
brane localization of overexpressed HECT ubiquitin ligases ap-
pears not to be essential to support viral budding, perhaps be-
cause the localized concentration of hundreds or thousands of
Gag molecules containing PPXY motifs acts as a potent re-
cruiting influence for WW domains. Nonetheless, the C2 do-
main potentiates the activity of dominant inhibitory WWP1
fragments, presumably because it would limit the diffusion of
the protein to the confines of the plasma membrane, increasing
the likelihood of encountering membrane associated viral pro-
teins. Similarly, the C2 domain of Rsp5 has been shown to fa-
cilitate the sorting of CPS into the yeast MVB pathway, but
mutants lacking this domain retain residual activity (Dunn et
al., 2004; Katzmann et al., 2004).
Overall, this study indicates that WWP1, WWP2, and
Itch are likely the most frequently used HECT ubiquitin ligases
during PPXY motif–dependent viral budding and that their
HECT ubiquitin ligase activity is required for this activity.
Moreover, these findings also suggest that, in addition to acting
as ubiquitin ligases, HECT domains have a previously unap-
preciated association with the class E pathway. Further work
will clarify the relationship between ubiquitin ligases, the sort-
ing of proteins at MVBs and the budding of enveloped viruses.
 
Materials and methods
 
Plasmid construction and mutagenesis
 
The HECT ubiquitin ligases used in this study were of human origin and
included Nedd4, Nedd4-L, BUL1, WWP1, WWP2, AIP4/Itch, Smurf1,
and Smurf2. The construction of plasmids expressing full-length and/or
truncated versions of these proteins, wild-type and mutant VPS4, MLV
Gag, GST-p12, and EbVP40 is described in the online supplemental
material. The MLV proviral plasmids pNCS (MLV) pNCS D-PY (MLV/
dPY) and pNCS P6-PY (MLV/HIVp6) (Yuan et al., 2000) were a gift
from S. Goff (Columbia University College of Physicians and Surgeons,
New York, NY). The construction of derivatives is described in the online
supplemental material.
 
MLV and EbVP40 viral particle formation assays
 
293T cells were transfected with MLV proviral plasmids or myc-tagged
EbVP40 expression vectors using Lipofectamine Plus (Invitrogen) and su-
pernatants were harvested at 24 h and 48 h after transfection for exper-
iments involving EbVP40 and MLV, respectively. Where the ability of
HECT ubiquitin ligases (or fragments thereof) to enhance or inhibit parti-
cle release was measured, various amounts of YFP-fusion protein ex-
pression plasmid were cotransfected. For both MLV and EbVP40, the
culture supernatants were clarified by low speed centrifugation and vi-
ral particles were harvested by centrifugation through a 20% sucrose
cushion at 100,000 
 
g
 
 for 1.5 h. Viral proteins in cell and viral lysates
were analyzed by Western blotting.
 
Protein–protein interaction assays
 
For two-hybrid assays, yeast cells (Y190) were transformed with Gal4
and VP16 fusion protein expression plasmids and protein–protein inter-
actions were measured by 
 
 
 
-galactosidase reporter activity as de-
scribed previously (Martin-Serrano et al., 2001). For GST-fusion protein
co-precipitation assays, 293T cells were transfected with pCAGGS/
GST-p12 expression plasmids. 48 h later, GST-p12 and proteins bound
to it were precipitated using glutathione-Sepharose beads, eluted, and
analyzed by Western blotting as described previously (Martin-Serrano
et al., 2003a).
 
Western blot analyses
 
Virion and cell lysates or bead eluates were separated on 10 or 12%
acrylamide gels and transferred to nitrocellulose membranes. The blots
were probed with primary antibodies against WWP1, WWP2, and Itch
(Santa Cruz Biotechnology, Inc.) MLV CA, the Myc epitope tag (9E10),
or GFP (Roche), followed by peroxidase-conjugated secondary antibod-
ies, and developed with chemiluminescent substrate reagents (Pierce
Chemical Co.).
 
Microscopy
 
293T cells were plated in 35-mm coverslip dishes (Mattek) and transfected
with a variable amount of a pCR3.1/YFP derivative expressing a YFP-
HECT ubiquitin ligase fusion protein along with 800 ng of a wild-type or
mutant pCAGGS/MLVGag-CFP or pCR3.1/CFP-EbVP40 plasmid. Alter-
natively, the YFP-fusion protein expression plasmids were cotransfected
with 300 ng of pCR3.1/CFP/VPS4. The cells were fixed with PFA 24 h af-
ter transfection and images were collected and processed as described in
the online supplemental material.
 
MLV infectivity assays
 
293T cells were transfected with wild-type, chimeric or mutant MLV provi-
ral plasmids, a vesicular stomatitis virus-G envelope expression plasmid
and pMSCV/Tat. HeLa P4/R5 cells, which carry a Tat responsive HIV-1
LTR-
 
LacZ reporter gene, were used as targets to measure infectious MLV
production, as described previously (Martin-Serrano et al., 2004). In some
experiments, where the ability of ubiquitin ligase fragments to inhibit parti-
cle formation was measured, various amounts of YFP-fusion protein expres-
sion plasmid were cotransfected with the viral constructs.
Online supplemental material
Details of the plasmid construction, microscopy, and image analysis are
contained herein. Online supplemental material is available at http://
www.jcb.org/cgi/content/full/jcb.200408155/DC1.
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